MEDICUS PHARMA LTD. Gain (Loss) on Extinguishment of Debt
MEDICUS PHARMA LTD. (MDCX) reported Gain (Loss) on Extinguishment of Debt of -$25.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-25
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was -$25.00K.
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for fiscal 2025 was -$25.00K.
- MEDICUS PHARMA LTD. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$25.00K derived: sum of 2 quarters · filed 2026-03-25 | -$25.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$25.00K 10-Q · filed 2025-11-14 | -$25.00K 10-Q · filed 2025-11-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |